Related Experiment Video
Updated: Jul 31, 2026
Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count
Published on: July 11, 2012
Antibacterial Activity of CdTe/ZnS Quantum Dot-β Lactum Antibiotic Conjugates
Sandeep K Vaishanav1, Jyoti Korram2, Tikendra K Verma3
1State Forensic Science Laboratory, Police line Campus, Tikrapara, Raipur, C.G., 492001, India.
Abstract:
β-Lactum antibiotics are broad class of antibiotics which kills bacteria by inhibiting the formation of peptidoglycan that constitutes the bacterial cell wall. The resistance that develops in bacteria for antibiotics led the scientific world to think about the future aspects for modifying the way through which antibiotics are acted on the bacteria and become lethal for them. In this consequence, the potential of latest marketed antibiotics e.g. Amoxiciline (I), ceftazidim (II) have been evaluated after being conjugated with quantum dots. The surface of quantum dots has been conjugated with antibiotics by carbodiimide coupling with the help of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) as conjugating agent between antibiotic and functionalized quantum dots. The antibacterial properties of QD-conjugated antibiotics have been determined by disc diffusion assay. The potency of QD-conjugated antibiotics has been estimated by determining their MIC50 for the selected strain of Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria. Minimum inhibitory concentration study, minimum bactericidal concentration and growth pattern analysis revealed that QD-antibiotic conjugates showed slightly more prospective than pure native antibiotics against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria.
Insights
Quantum dot-conjugated antibiotics show enhanced antibacterial properties against common Gram-negative and Gram-positive bacteria. This novel approach offers a promising strategy to overcome antibiotic resistance.
Area of Science:
- * Nanotechnology and Materials Science
- * Microbiology and Infectious Diseases
- * Pharmaceutical Sciences
Background:
- * Beta-lactam antibiotics are crucial for combating bacterial infections by inhibiting cell wall synthesis.
- * Rising antibiotic resistance necessitates innovative strategies to enhance antimicrobial efficacy.
- * Quantum dots (QDs) offer unique optical and electronic properties for potential biomedical applications.
Purpose of the Study:
- * To conjugate Amoxicillin and Ceftazidime with quantum dots.
- * To evaluate the enhanced antibacterial activity of these conjugates against Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria.
- * To compare the efficacy of QD-antibiotic conjugates with native antibiotics.
Main Methods:
- * Antibiotic conjugation to functionalized quantum dots using carbodiimide coupling (EDC/NHS).
- * Antibacterial activity assessed via disc diffusion assay.
- * Potency determined by Minimum Inhibitory Concentration (MIC50), Minimum Bactericidal Concentration (MBC), and growth pattern analysis.
Main Results:
- * Successful conjugation of Amoxicillin and Ceftazidime to quantum dots.
- * QD-antibiotic conjugates demonstrated slightly enhanced antibacterial activity compared to native antibiotics.
- * Improved efficacy observed against both Escherichia coli and Staphylococcus aureus strains.
Conclusions:
- * Quantum dot conjugation can enhance the antibacterial potency of existing antibiotics.
- * This approach presents a viable strategy to combat antibiotic resistance.
- * Further research into QD-antibiotic conjugates holds promise for future antimicrobial therapies.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
01:25Clinical Significance of Antibiotic Resistance